Europe histopathology services market was valued at $6,882.53 Million in 2021, and is expected to reach $12,921.23 Million by 2031, registering a CAGR of 6.5% from 2021 to 2031.ย  Histopathology is the procedure of examining tissues to know more about various diseases and causes behind it. The tissues are observed under microscope in histopathology laboratory. This procedure involves to conduct biopsy. Histopathological services are extremely crucial as it enables histopathologists for detecting infection. Histopathology enables medical professionals to look for changes in cell which provide actual information of patient illness and the causes of disease. Histopathology services provide a diagnostic service for various types of cancer.

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

Acculabs Diagnostics UK Ltd, Cellular Pathology Services Limited, Great Ormond Street Hospital (GOSH) Laboratory, HCA Laboratories UK, Laboratoire Cerba, Sonic Healthcare Limited, Spire Healthcare Group Plc, Targos Molecular Pathology GmbH


๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/4103

Surge in popularity of immune-histochemistry for visualization of cellular components to diagnose wide range of chronic diseases is one of the major factor, which boost the growth of the histopathology services market in Europe.ย In addition, the medical device sector has opened new approaches and collaborations in the industry to respond to the urgent needs of the pandemic. Furthermore, according to World Health Organization, the Globocan Data 2020, around 531,086 cases of breast cancer were estimated in Europe. Thus, rise in number of breast cancer cases surge the usage of breast biopsy which drives the growth of the Europe histopathology services market.

According to the International Diabetes Federation, in 2021, approximately 61 million adults between 20 and 79 years were estimated suffer with diabetes in Europe. The total number of people living with diabetes is projected to rise to 69 million by 2045. Thus, rise in burden of diabetes increases the demand for diagnostic tests and thus, surges the usage of histopathology services.

For instance, according to Globocan 2020, it was estimated that there were approximately 477,534 incidences of lung cancer and approximately 181,709 cases of rectum cancer in Europe. Thus, rise in number of patients with lung cancer and rectum cancer surge the usage of lung biopsy and renal biopsy which fuels the growth of the Europe histopathology services market.

๐๐ฎ๐ฒ ๐๐จ๐ฐ https://www.alliedmarketresearch.com/checkout-final/6f3fa247f923eaa0831d6df96b2e11a5

However, high cost of acquisition and maintenance of histopathology services and shortage of skilled professionals to operate equipment are some key challenges that hinder the growth of the market. On the contrary, increase in number of diagnostic laboratories and surge in the demand for histopathology services create an opportunity for the key players to tap and capitalize their presence in the market.

The Europe histopathology services market is studied on the basis of type of examination and country. By type of examination, the surgical specimen segment dominated the market in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to rise in number of surgical procedures. In addition, the liver biopsy segment is expected to register higher CAGR during the forecast period owing to rise in cases of liver cancer leading to surge the usage of liver biopsy. This is the vital factor that drives the growth of the market.


๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/4103


๐Š๐„๐˜ ๐…๐ˆ๐๐ƒ๐ˆ๐๐†๐’ ๐Ž๐… ๐“๐‡๐„ ๐’๐“๐”๐ƒ๐˜

  • By type of examination, the surgical specimen segment was the highest contributor to the Europe Histopathology Services Market in 2021.
  • Germany accounted for a majority of the histopathology services market share in 2021, and is anticipated to remain dominant during the forecast period.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Leave a comment

Your email address will not be published. Required fields are marked *